These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34603382)

  • 1. Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine.
    Zhou G; Li Y; Li S; Liu H; Xu F; Lai X; Zhang Q; Xu J; Wan S
    Front Genet; 2021; 12():719451. PubMed ID: 34603382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.
    Li L; Hann HW; Wan S; Hann RS; Wang C; Lai Y; Ye X; Evans A; Myers RE; Ye Z; Li B; Xing J; Yang H
    Sci Rep; 2016 Apr; 6():23992. PubMed ID: 27063412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
    Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma.
    Wan X; Zhai X; Yan Z; Yang P; Li J; Wu D; Wang K; Xia Y; Shen F
    Oncotarget; 2016 Dec; 7(50):83806-83816. PubMed ID: 27566566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study.
    Wang L; Lin N; Lin K; Xiao C; Wang R; Chen J; Zhou W; Liu J
    J Gastrointest Surg; 2021 May; 25(5):1172-1183. PubMed ID: 32440804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
    J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma.
    Kim MP; Yang JK; Jun BG; Kim YD; Cheon GJ; Jung HJ; Yoo JJ; Kim SG; Kim YS; Jeong SW; Jang JY; Kim HS; Lee SH
    J Viral Hepat; 2021 Jul; 28(7):1011-1018. PubMed ID: 33759295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
    He CB; Lao XM; Lin XJ
    Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
    Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
    World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative.
    Wang K; Jiang G; Jia Z; Zhu X; Ni C
    Medicine (Baltimore); 2018 Jun; 97(22):e10940. PubMed ID: 29851833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma.
    English K; Brodin NP; Shankar V; Zhu S; Ohri N; Golowa YS; Cynamon J; Bellemare S; Kaubisch A; Kinkhabwala M; Kalnicki S; Garg MK; Guha C; Kabarriti R
    JAMA Netw Open; 2020 Nov; 3(11):e2023942. PubMed ID: 33151315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
    Kim SS; Cho HJ; Won JH; Bae JI; Kang DR; Lee JD; Shin SJ; Lee KM; Yoo BM; Kim JK; Lee JH; Ahn SJ; Park JH; Cho SW; Cheong JY
    Cytokine; 2015 Dec; 76(2):449-457. PubMed ID: 26163999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection.
    Kuang X; Ye J; Xie Z; Bai T; Chen J; Gong W; Qi L; Zhong J; Ma L; Peng N; Xiang B; Wu F; Wu G; Ye H; Wang C; Li L
    Oncol Lett; 2018 Oct; 16(4):4937-4944. PubMed ID: 30214612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
    Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
    Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
    Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
    Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.